Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:27:59.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide notice explains that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-25T01:30:51.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T01:05:20.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:44:56.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study history now includes a new revision entry (v3.7.0) and removes the previous revision (v3.6.6), reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-09-20T00:34:01.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    New Revision: v3.6.6 was added to the study record history and Revision: v3.6.5 was removed, updating the revision log to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-08-29T19:23:26.000Z thumbnail image

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.